2025年10月29日晚， 联影医疗 公布了其2025年第三季度及前三季度业绩： 第三季度公司实现营业收入约 28.43 亿元，同比增长约 75.41% ；前三季度累计营 收约 88.59 亿元，同比增长约 27.39%。此外，前三季度归属于上市公司股东净利润约 11.20 亿元，同比增长约 66.91%。 这组数据标志着联影在高端影像设备领域的增长态势进一步显现，公司正从"国内追赶"迈向"全球标杆"的角色。 # 核心数据亮点 | 项目 | 本报告期 | 本报告期比 上年同期増 | | 年初至报告 期末比上年 | | --- | --- | --- | --- | --- | | | | 减变动幅度 | 年初至报告期末 | 同期增减变 | | | | (%) | | 动幅度(%) | | 营业收入 | 2.843.014.990.57 | 75. 41 | 8, 858, 916, 392. 73 | 27. 39 | | 利润总额 | 105,580,595.53 | 不适用 | 1, 178, 552, 726. 27 | 65. 56 | | 归属于上市公司股东 | 122, 216, 265. 88 ...

Group 1 - The medical device sector has seen a continuous rise, with the medical device ETF (562600) achieving four consecutive days of gains, closing up 0.62% on August 25. Notable stocks such as Meihao Medical, Lepu Medical, and Toukeng Life have seen significant increases of 14.49%, 13.55%, and 10.70% respectively [1] - The medical device ETF (562600) has attracted substantial capital, with net inflows recorded on 4 out of the last 5 trading days, totaling 46.25 million yuan, and 8 out of the last 10 trading days, amounting to 84.87 million yuan [1] - The recent press conference on the "14th Five-Year Plan" emphasized comprehensive support for the high-quality development of the pharmaceutical industry, including reforms in review and approval systems and the establishment of expedited approval channels for breakthrough therapies [1] Group 2 - Everbright Securities recommends increasing allocation to the medical device sector, anticipating that supportive policies from the National Medical Products Administration will drive rapid development in high-end imaging equipment, surgical robots, brain-computer interfaces, and AI+ healthcare [2] - The demand in the medical device industry, particularly in the equipment sector, has significantly improved since the second half of 2024, with expectations for a gradual recovery in industry scale growth [2] - The medical device ETF (562600) serves as a convenient tool for investors to capture growth opportunities in the medical device sector, tracking the CSI All Share Medical Device Index, which includes 100 representative companies across core medical fields [2]